Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Theratechnologies to Announce First Quarter 2023 Financial Results and Provide Business Update By: Theratechnologies via GlobeNewswire April 03, 2023 at 07:30 AM EDT MONTREAL, April 03, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will report financial results for its first quarter 2023 ended February 28, on Wednesday, April 12, 2023. The conference call will be held on Wednesday, April 12, 2023, hosted by Mr. Paul Lévesque, President and Chief Executive Officer, and begin at 8:30 a.m. ET. Joining Mr. Lévesque on the call will be other members of the management team, including Chief Financial Officer Mr. Philippe Dubuc, Chief Medical Officer Dr. Christian Marsolais, and Global Commercial Officer Mr. John Leasure, who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information is below: CONFERENCE CALL INFORMATIONConference Call Date:April 12, 2023Conference Call Time:8:30 AM ETNorth America Dial-in:1-877-513-4119International Dial-in:1-412-902-6615Access Code:4314981CONFERENCE CALL REPLAYNorth America Dial-in:1-877-344-7529International Dial-in:1-412-317-0088Replay Access Code: 8857934Replay End DateApril 19, 2023 The live conference call will be accessible via webcast at:https://edge.media-server.com/mmc/p/nt9j2fgq About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Investor Inquiries:Elif McDonaldSenior Director, Investor Relationsir@theratech.com1-438-315-8563 Media Inquiries:Julie SchneidermanSenior Director, Communications and Corporate Affaires communications@theratech.com1 514 336-7800 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Theratechnologies to Announce First Quarter 2023 Financial Results and Provide Business Update By: Theratechnologies via GlobeNewswire April 03, 2023 at 07:30 AM EDT MONTREAL, April 03, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will report financial results for its first quarter 2023 ended February 28, on Wednesday, April 12, 2023. The conference call will be held on Wednesday, April 12, 2023, hosted by Mr. Paul Lévesque, President and Chief Executive Officer, and begin at 8:30 a.m. ET. Joining Mr. Lévesque on the call will be other members of the management team, including Chief Financial Officer Mr. Philippe Dubuc, Chief Medical Officer Dr. Christian Marsolais, and Global Commercial Officer Mr. John Leasure, who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information is below: CONFERENCE CALL INFORMATIONConference Call Date:April 12, 2023Conference Call Time:8:30 AM ETNorth America Dial-in:1-877-513-4119International Dial-in:1-412-902-6615Access Code:4314981CONFERENCE CALL REPLAYNorth America Dial-in:1-877-344-7529International Dial-in:1-412-317-0088Replay Access Code: 8857934Replay End DateApril 19, 2023 The live conference call will be accessible via webcast at:https://edge.media-server.com/mmc/p/nt9j2fgq About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Investor Inquiries:Elif McDonaldSenior Director, Investor Relationsir@theratech.com1-438-315-8563 Media Inquiries:Julie SchneidermanSenior Director, Communications and Corporate Affaires communications@theratech.com1 514 336-7800
MONTREAL, April 03, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will report financial results for its first quarter 2023 ended February 28, on Wednesday, April 12, 2023. The conference call will be held on Wednesday, April 12, 2023, hosted by Mr. Paul Lévesque, President and Chief Executive Officer, and begin at 8:30 a.m. ET. Joining Mr. Lévesque on the call will be other members of the management team, including Chief Financial Officer Mr. Philippe Dubuc, Chief Medical Officer Dr. Christian Marsolais, and Global Commercial Officer Mr. John Leasure, who will be available to answer questions from participants following prepared remarks. Participants are encouraged to join the call at least ten minutes in advance to secure access. Conference call dial-in and replay information is below: CONFERENCE CALL INFORMATIONConference Call Date:April 12, 2023Conference Call Time:8:30 AM ETNorth America Dial-in:1-877-513-4119International Dial-in:1-412-902-6615Access Code:4314981CONFERENCE CALL REPLAYNorth America Dial-in:1-877-344-7529International Dial-in:1-412-317-0088Replay Access Code: 8857934Replay End DateApril 19, 2023 The live conference call will be accessible via webcast at:https://edge.media-server.com/mmc/p/nt9j2fgq About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Investor Inquiries:Elif McDonaldSenior Director, Investor Relationsir@theratech.com1-438-315-8563 Media Inquiries:Julie SchneidermanSenior Director, Communications and Corporate Affaires communications@theratech.com1 514 336-7800